NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,540 | +79.6% | 7,626,388 | +73.5% | 0.02% | +90.0% |
| Q2 2023 | $2,528 | +471.9% | 4,396,020 | +597.5% | 0.01% | +400.0% |
| Q1 2023 | $442 | +750.0% | 630,249 | +2606.6% | 0.00% | – |
| Q4 2022 | $52 | -100.0% | 23,286 | -92.7% | 0.00% | -100.0% |
| Q2 2019 | $11,351,000 | +194.8% | 319,029 | +178.3% | 0.05% | +217.6% |
| Q1 2019 | $3,851,000 | +3082.6% | 114,635 | +3017.6% | 0.02% | +1600.0% |
| Q4 2018 | $121,000 | -81.3% | 3,677 | -65.3% | 0.00% | -66.7% |
| Q3 2018 | $646,000 | – | 10,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |